subject: UMLS:C5226606

object_name: Osteoporosis, CTCAE 3.0


subject: UNII:2P6O7CFW5K

subject_name: Triheptanoin

object_name: Citrate transporter deficiency

tested_intervention: yes


subject: CHEBI:109549

subject_name: Ramelteon

object_name: quadriplegia


subject: CHEBI:109549

object_name: spinal cord injury


subject: CHEBI:6121

subject_name: Ketamine

object_name: Postoperative Nausea


subject: CHEBI:6121

object_name: Vomiting, Postoperative


subject: CHEBI:6121

object_name: Dentofacial Deformities


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: venous thromboembolism


subject: CHEBI:39548

object_name: thrombophilia due to thrombin defect


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: gastroesophageal adenocarcinoma

tested_intervention: unsure


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UMLS:C4725109


subject: UMLS:C5706540

subject_name: Anti-CTLA-4 Monoclonal Antibody SHR-8068


subject: UMLS:C5706540

object_name: gastric adenocarcinoma


subject: PUBCHEM.COMPOUND:71301229

subject_name: Xelox


subject: CHEBI:49960

subject_name: Vandetanib

object_name: familial medullary thyroid carcinoma


subject: CHEBI:49960

object_name: medullary thyroid gland carcinoma


subject: CHEBI:49960

object_name: multiple endocrine neoplasia type 2B


subject: CHEBI:49960

object_name: multiple endocrine neoplasia type 2A


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Depressed mood


subject: CHEBI:119915

object_name: Cancer patients and suicide and depression


subject: CHEBI:119915

object_name: Depressed - symptom


subject: CHEBI:119915

object_name: Depression, CTCAE


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:44915


subject: CHEBI:44915


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: neuritis


subject: CHEBI:74705

subject_name: Met-Leu


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: Hemolysis


subject: CHEBI:16480

object_name: Hemolysis - observation


subject: CHEBI:16480

object_name: Hemolysis, CTCAE


subject: MESH:C000613032

object_name: non-small cell lung carcinoma


subject: CHEBI:39548

object_name: angina unstable


subject: CHEBI:132082

subject_name: Entinostat

object_name: Advanced breast cancer


subject: UMLS:C2348411

object_name: acute myeloid leukemia


subject: CHEBI:231702

subject_name: Tirbanibulin


subject: CHEBI:68841

subject_name: Gadobutrol

object_name: liver cancer


subject: CHEBI:68841

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:68841

object_name: liver disorder


subject: CHEBI:68841

object_name: liver carcinoma


subject: UNII:HOY74VZE0M

subject_name: gadoxetate


subject: UNII:HOY74VZE0M


subject: UNII:HOY74VZE0M


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Epidermal growth factor receptor positive non-small cell lung cancer


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: CHEBI:109549

subject_name: Ramelteon

object_name: obstructive sleep apnea syndrome


subject: UNII:Y3834SIK5F

subject_name: PORFIMER SODIUM

object_name: superficial urinary bladder carcinoma


subject: CHEBI:131168

subject_name: Afuresertib

object_name: Childhood Solid Neoplasm


subject: CHEBI:131168

object_name: Adult Solid Neoplasm


subject: CHEBI:131168

object_name: Solid Neoplasm


subject: CHEBI:131168

object_name: triple-negative breast carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297858

subject_name: BUDIGALIMAB


subject: UMLS:C4527193


subject: UMLS:C5206750

subject_name: Eltivutabart


subject: UNII:01KC87F8FE

object_name: malignant soft tissue neoplasm


subject: UNII:01KC87F8FE

object_name: sarcoma


subject: CHEBI:3423

subject_name: Carmustine


subject: CHEBI:3423


subject: UMLS:C3852764

subject_name: PEG-rhG-CSF

object_name: pancreatic neoplasm


subject: UMLS:C3852764

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3852764

object_name: malignant pancreatic neoplasm


subject: UMLS:C4278755

object_name: essential hypertension


subject: CHEBI:4877

subject_name: Ethambutol

object_name: tuberculosis


subject: UMLS:C4733632

subject_name: Clostridium butyricum CBM 588 Probiotic Strain

object_name: rectal carcinoma


subject: UMLS:C4733632

object_name: rectal cancer


subject: UMLS:C4733632

object_name: Childhood Rectal Carcinoma


subject: UMLS:C4733632

object_name: bowel dysfunction


subject: UMLS:C4733632

object_name: Ileostomy - stoma


subject: UMLS:C4733632

object_name: microbial disease


subject: CHEBI:4315

subject_name: Danazol

object_name: thrombotic thrombocytopenic purpura


subject: CHEBI:4315

object_name: Thrombotic Thrombocytopenic Purpura, CTCAE


subject: MESH:C000627770

subject_name: folfirinox

object_name: colorectal neoplasm


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab

object_name: Node-negative breast cancer


subject: UNII:K16AIQ8CTM

object_name: progesterone receptor-negative breast cancer


subject: UNII:K16AIQ8CTM

object_name: estrogen receptor-negative breast cancer


subject: UNII:SE2KH7T06F


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: CHEBI:52763

object_name: chronic myelomonocytic leukemia


subject: CHEBI:52763

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:52763

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:52763

object_name: acute myeloid leukemia


subject: CHEBI:52763

object_name: myelofibrosis


subject: UMLS:C0018284

subject_name: Growth Factor


subject: UMLS:C0018284


subject: UMLS:C0018284


subject: UMLS:C0018284

object_name: Myelodysplasia


subject: UMLS:C0018284


subject: UMLS:C0018284


subject: UMLS:C0018284

object_name: adult lymphoma


subject: UMLS:C0018284

object_name: lymphoma


subject: UMLS:C0018284

object_name: pediatric lymphoma


subject: UMLS:C1562292

subject_name: Incretins

object_name: ST-elevation myocardial infarction


subject: UMLS:C1562292

object_name: ST Elevation Myocardial Infarction


subject: UMLS:C1562292

object_name: coronary artery disorder


subject: UMLS:C1562292

object_name: coronary atherosclerosis


subject: UMLS:C1562292

object_name: type 2 diabetes mellitus


subject: UMLS:C1562292

object_name: Diabetes


subject: UMLS:C1562292

object_name: diabetes mellitus


subject: UMLS:C1562292

object_name: angina unstable


subject: GTOPDB:11376

subject_name: bintrafusp alfa

object_name: lung; mesothelioma


subject: CHEMBL.COMPOUND:CHEMBL4298024

subject_name: BINTRAFUSP ALFA


subject: UMLS:C4086994


subject: CHEBI:28911

subject_name: cob(III)alamin

object_name: Anemia of pregnancy


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: CHEBI:176843

subject_name: vitamin B12


subject: UMLS:C0086024

subject_name: cobalamins


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: MESH:D056692

subject_name: Prebiotics

object_name: resistant hypertension


subject: MESH:D056692

object_name: Hypertension resistant to conventional therapy


subject: MESH:D056692

object_name: hypertension


subject: MESH:D056692

object_name: Hypertension, CTCAE


subject: UMLS:C3897258

subject_name: Ubidecarenone Nanodispersion BPM31510n

object_name: squamous cell carcinoma


subject: PUBCHEM.COMPOUND:89455219

subject_name: tirabrutinib

object_name: chronic idiopathic urticaria


subject: CHEBI:45924

subject_name: Trimethoprim

object_name: anemia


subject: CHEBI:31409

object_name: liver carcinoma


subject: UMLS:C0772142

subject_name: clemizole HCl


subject: CHEBI:3423

subject_name: Carmustine

object_name: PALB2 Gene Mutation


subject: CHEBI:3423

object_name: BRCA2 gene mutation


subject: CHEBI:3423

object_name: BRCA1 gene mutation


subject: CHEBI:3423

object_name: Carcinoma breast stage IV


subject: CHEBI:3423

object_name: pancreatic neoplasm


subject: CHEBI:3423

object_name: exocrine pancreatic carcinoma


subject: CHEBI:3423

object_name: malignant pancreatic neoplasm


subject: CHEBI:3423

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:3423

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:3423

object_name: stage IV pancreatic cancer


subject: CHEBI:3423

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:3423

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: CHEBI:3423

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:3423

object_name: malignant neoplasm of breast stage IV


subject: CHEBI:3423

object_name: Her2-receptor negative breast cancer


subject: CHEBI:3423

object_name: breast adenocarcinoma


subject: CHEBI:3423

object_name: pancreatic acinar cell carcinoma


subject: CHEBI:3423

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C3854029

subject_name: antiseptics ethanol

object_name: PALB2 Gene Mutation


subject: UMLS:C3854029

object_name: BRCA2 gene mutation


subject: UMLS:C3854029

object_name: BRCA1 gene mutation


subject: UMLS:C3854029

object_name: Carcinoma breast stage IV


subject: UMLS:C3854029

object_name: pancreatic neoplasm


subject: UMLS:C3854029

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3854029

object_name: malignant pancreatic neoplasm


subject: UMLS:C3854029

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C3854029

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C3854029

object_name: stage IV pancreatic cancer


subject: UMLS:C3854029

object_name: Pancreatic adenocarcinoma metastatic


subject: UMLS:C3854029

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: UMLS:C3854029

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C3854029

object_name: malignant neoplasm of breast stage IV


subject: UMLS:C3854029

object_name: Her2-receptor negative breast cancer


subject: UMLS:C3854029

object_name: breast adenocarcinoma


subject: UMLS:C3854029

object_name: pancreatic acinar cell carcinoma


subject: UMLS:C3854029

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C3854030

subject_name: CNS depressants ethanol

object_name: PALB2 Gene Mutation


subject: UMLS:C3854030

object_name: BRCA2 gene mutation


subject: UMLS:C3854030

object_name: BRCA1 gene mutation


subject: UMLS:C3854030

object_name: Carcinoma breast stage IV


subject: UMLS:C3854030

object_name: pancreatic neoplasm


subject: UMLS:C3854030

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3854030

object_name: malignant pancreatic neoplasm


subject: UMLS:C3854030

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C3854030

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C3854030

object_name: stage IV pancreatic cancer


subject: UMLS:C3854030

object_name: Pancreatic adenocarcinoma metastatic


subject: UMLS:C3854030

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: UMLS:C3854030

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C3854030

object_name: malignant neoplasm of breast stage IV


subject: UMLS:C3854030

object_name: Her2-receptor negative breast cancer


subject: UMLS:C3854030

object_name: breast adenocarcinoma


subject: UMLS:C3854030

object_name: pancreatic acinar cell carcinoma


subject: UMLS:C3854030

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:16236

subject_name: Ethanol

object_name: PALB2 Gene Mutation


subject: CHEBI:16236

object_name: BRCA2 gene mutation


subject: CHEBI:16236

object_name: BRCA1 gene mutation


subject: CHEBI:16236

object_name: Carcinoma breast stage IV


subject: CHEBI:16236

object_name: pancreatic neoplasm


subject: CHEBI:16236

object_name: exocrine pancreatic carcinoma


subject: CHEBI:16236

object_name: malignant pancreatic neoplasm


subject: CHEBI:16236

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:16236

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:16236

object_name: stage IV pancreatic cancer


subject: CHEBI:16236

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:16236

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: CHEBI:16236

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:16236

object_name: malignant neoplasm of breast stage IV


subject: CHEBI:16236

object_name: Her2-receptor negative breast cancer


subject: CHEBI:16236

object_name: breast adenocarcinoma


subject: CHEBI:16236

object_name: pancreatic acinar cell carcinoma


subject: CHEBI:16236

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:82339

subject_name: Merphalan

object_name: PALB2 Gene Mutation


subject: CHEBI:82339

object_name: BRCA2 gene mutation


subject: CHEBI:82339

object_name: BRCA1 gene mutation


subject: CHEBI:82339

object_name: Carcinoma breast stage IV


subject: CHEBI:82339

object_name: pancreatic neoplasm


subject: CHEBI:82339

object_name: exocrine pancreatic carcinoma


subject: CHEBI:82339

object_name: malignant pancreatic neoplasm


subject: CHEBI:82339

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:82339

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:82339

object_name: stage IV pancreatic cancer


subject: CHEBI:82339

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:82339

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: CHEBI:82339

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:82339

object_name: malignant neoplasm of breast stage IV


subject: CHEBI:82339

object_name: Her2-receptor negative breast cancer


subject: CHEBI:82339

object_name: breast adenocarcinoma


subject: CHEBI:82339

object_name: pancreatic acinar cell carcinoma


subject: CHEBI:82339

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:28876

subject_name: Melphalan

object_name: PALB2 Gene Mutation


subject: CHEBI:28876

object_name: BRCA2 gene mutation


subject: CHEBI:28876

object_name: BRCA1 gene mutation


subject: CHEBI:28876

object_name: Carcinoma breast stage IV


subject: CHEBI:28876

object_name: pancreatic neoplasm


subject: CHEBI:28876

object_name: exocrine pancreatic carcinoma


subject: CHEBI:28876

object_name: malignant pancreatic neoplasm


subject: CHEBI:28876

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:28876

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:28876

object_name: stage IV pancreatic cancer


subject: CHEBI:28876

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:28876

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: CHEBI:28876

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:28876

object_name: malignant neoplasm of breast stage IV


subject: CHEBI:28876

object_name: Her2-receptor negative breast cancer


subject: CHEBI:28876

object_name: breast adenocarcinoma


subject: CHEBI:28876

object_name: pancreatic acinar cell carcinoma


subject: CHEBI:28876

object_name: pancreatic ductal adenocarcinoma


subject: PUBCHEM.COMPOUND:126842313

subject_name: Vitamin B12b

object_name: PALB2 Gene Mutation


subject: PUBCHEM.COMPOUND:126842313

object_name: BRCA2 gene mutation


subject: PUBCHEM.COMPOUND:126842313

object_name: BRCA1 gene mutation


subject: PUBCHEM.COMPOUND:126842313

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:126842313

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:126842313

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:126842313

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:126842313

object_name: Metastatic malignant neoplasm to pancreas


subject: PUBCHEM.COMPOUND:126842313

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:126842313

object_name: stage IV pancreatic cancer


subject: PUBCHEM.COMPOUND:126842313

object_name: Pancreatic adenocarcinoma metastatic


subject: PUBCHEM.COMPOUND:126842313

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: PUBCHEM.COMPOUND:126842313

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:126842313

object_name: malignant neoplasm of breast stage IV


subject: PUBCHEM.COMPOUND:126842313

object_name: Her2-receptor negative breast cancer


subject: PUBCHEM.COMPOUND:126842313

object_name: breast adenocarcinoma


subject: PUBCHEM.COMPOUND:126842313

object_name: pancreatic acinar cell carcinoma


subject: PUBCHEM.COMPOUND:126842313

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:27786

subject_name: Hydroxocobalamin

object_name: PALB2 Gene Mutation


subject: CHEBI:27786

object_name: BRCA2 gene mutation


subject: CHEBI:27786

object_name: BRCA1 gene mutation


subject: CHEBI:27786

object_name: Carcinoma breast stage IV


subject: CHEBI:27786

object_name: pancreatic neoplasm


subject: CHEBI:27786

object_name: exocrine pancreatic carcinoma


subject: CHEBI:27786

object_name: malignant pancreatic neoplasm


subject: CHEBI:27786

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:27786

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:27786

object_name: stage IV pancreatic cancer


subject: CHEBI:27786

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:27786

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: CHEBI:27786

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:27786

object_name: malignant neoplasm of breast stage IV


subject: CHEBI:27786

object_name: Her2-receptor negative breast cancer


subject: CHEBI:27786

object_name: breast adenocarcinoma


subject: CHEBI:27786

object_name: pancreatic acinar cell carcinoma


subject: CHEBI:27786

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: PALB2 Gene Mutation


subject: CHEBI:38290

object_name: BRCA2 gene mutation


subject: CHEBI:38290

object_name: BRCA1 gene mutation


subject: CHEBI:38290

object_name: Carcinoma breast stage IV


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: CHEBI:16581

subject_name: Pregnenolone

object_name: cannabis abuse


subject: UNII:AHU547PI9H

subject_name: Ferric derisomaltose

object_name: Heart Failure, CTCAE


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: Anoxic Encephalopathy


subject: CHEBI:6887

object_name: Altered Level of Consciousness


subject: CHEBI:6887

object_name: severe traumatic brain injury


subject: CHEBI:6887

object_name: ocular motor apraxia, Cogan type


subject: CHEBI:76018

subject_name: Riociguat

object_name: COPD, severe early onset


subject: CHEBI:76018

object_name: chronic obstructive pulmonary disease


subject: UMLS:C2717562


subject: UMLS:C2717562


subject: CHEBI:52763

object_name: pulmonary hypertension


subject: CHEBI:52763


subject: CHEBI:40799

subject_name: Boldione

object_name: metastatic prostate carcinoma


subject: UNII:M6LC47TUG3

subject_name: Gamitrinib

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:M6LC47TUG3

object_name: adult lymphoma


subject: UNII:M6LC47TUG3

object_name: lymphoma


subject: UNII:M6LC47TUG3

object_name: pediatric lymphoma


subject: UMLS:C5557605


subject: UMLS:C5557605


subject: UMLS:C5557605


subject: UMLS:C5557605


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Anaesthesia intubation complication


subject: CHEBI:6456

object_name: adverse effect to anesthesia


subject: CHEBI:28976

subject_name: carbonic acid

object_name: no feeling or sensation of skin


subject: CHEBI:28976

object_name: Sensory Loss


subject: CHEBI:28976


subject: CHEBI:28976


subject: UMLS:C2722820

subject_name: Bicarbonate preparation


subject: UMLS:C2722820


subject: UMLS:C2722820


subject: UMLS:C2722820


subject: MESH:D001639

subject_name: Bicarbonates


subject: MESH:D001639


subject: MESH:D001639


subject: MESH:D001639


subject: CHEBI:17544

subject_name: Bicarbonate Ion


subject: CHEBI:17544


subject: CHEBI:17544


subject: CHEBI:17544


subject: MESH:C422842

subject_name: tacholiquine

object_name: chronic bronchitis


subject: MESH:C422842


subject: MESH:C422842


subject: UMLS:C0965096


subject: UMLS:C0965096


subject: UMLS:C0965096


subject: PUBCHEM.COMPOUND:21183636

subject_name: Atosiban

object_name: Repeated implantation failure


subject: UMLS:C0078129


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: CHEBI:9667

object_name: vitiligo


subject: UMLS:C5815593

object_name: Idiopathic macular telangiectasia type 2


subject: UMLS:C5780032

subject_name: HUMAN CILIARY NEUROTROPHIC FACTOR


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: carcinoma of esophagus


subject: PUBCHEM.COMPOUND:70789204

object_name: esophageal cancer


subject: PUBCHEM.COMPOUND:70789204

object_name: Childhood Esophageal Carcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: neoplasm of esophagus


subject: UMLS:C1321600

subject_name: Silver nitrate stain

object_name: Granulation Tissue


subject: UMLS:C1321600

object_name: Wound healed (finding)


subject: CHEBI:32130

subject_name: Silver nitrate


subject: CHEBI:32130


subject: UMLS:C1161347

subject_name: Argentum nitricum, silver nitrate


subject: UMLS:C1161347


subject: CHEBI:9667


subject: CHEBI:9667


subject: CHEBI:50634

object_name: Central sleep apnea comorbid with opioid use


subject: CHEBI:27690

subject_name: Acetazolamide


subject: DRUGBANK:DB19248

subject_name: Bifidobacterium longum

object_name: acute pancreatitis


subject: DRUGBANK:DB17475

subject_name: Incomplete Freund's adjuvant

object_name: ocular melanoma


subject: DRUGBANK:DB17475

object_name: conjunctival cancer


subject: UMLS:C1328092

subject_name: Multi-epitope Melanoma Peptide Vaccine


subject: UMLS:C1328092


subject: UNII:GN2UOJ9QUZ

subject_name: TETANUS TOXOID HELPER PEPTIDE


subject: UNII:GN2UOJ9QUZ

object_name: uveal melanoma


subject: UNII:GN2UOJ9QUZ


subject: UMLS:C1515333

subject_name: Tetanus Toxoid Helper Peptide


subject: UMLS:C1515333


subject: UMLS:C1515333


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: anovulation


subject: CHEBI:89324

object_name: Female infertility associated with anovulation


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Adult Penile Carcinoma


subject: UNII:52CMI0WC3Y

object_name: penis carcinoma


subject: UNII:52CMI0WC3Y

object_name: penile cancer


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: sarcoidosis


subject: UNII:FYS6T7F842

object_name: sarcoidosis, susceptibility to, 1


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: tonsillitis


subject: CHEBI:4466

object_name: Enlargement of tonsil or adenoid


subject: CHEBI:4466

object_name: adenoiditis


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UMLS:C1134664

object_name: renal cell carcinoma


subject: UMLS:C2987725

object_name: plasma cell myeloma


subject: CHEBI:63453

object_name: cancer


subject: CHEBI:63453

object_name: neoplasm


subject: CHEBI:229764

subject_name: Selinexor

object_name: Small cell lung cancer recurrent


subject: UMLS:C3714111

object_name: lymphopenia


subject: UMLS:C3714111

object_name: Lymphopenia, CTCAE


subject: CHEBI:53261

subject_name: poly(p-phenylenevinylene) macromolecule

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:60581

subject_name: poly(p-phenylenevinylene) polymer


subject: UNII:F5UM2KM3W7

subject_name: BENZALKONIUM CHLORIDE

object_name: eye disorder


subject: CHEBI:135611

subject_name: Benzalkonium


subject: UMLS:C1522385

subject_name: Recombinant Gonadotropin

object_name: infertility


subject: UNII:AJ212MS2O2

object_name: type 2 diabetes mellitus


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: type 1 diabetes mellitus 1


subject: CHEBI:73604

object_name: type 1 diabetes mellitus


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: neuroma


subject: PUBCHEM.COMPOUND:6096882

object_name: Neuroma of amputation stump


subject: PUBCHEM.COMPOUND:6096882

object_name: Neuroma of lower limb


subject: PUBCHEM.COMPOUND:6096882

object_name: Neuroma of upper limb


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: CHEBI:5558

subject_name: Guanfacine

object_name: post-traumatic stress disorder


subject: PUBCHEM.COMPOUND:53387035

subject_name: Pradigastat

object_name: hyperlipoproteinemia


subject: UMLS:C4045958


subject: CHEBI:6339

subject_name: Etoricoxib

object_name: Axial Spondyloarthritis


subject: CHEBI:49662

subject_name: Indomethacin


subject: UMLS:C0939354

subject_name: Indomethacin SR


subject: CHEBI:77543

subject_name: Ebselen

object_name: Cochlear trauma


subject: CHEBI:77543

object_name: deafness


subject: CHEBI:77543

object_name: hearing loss by exam


subject: DRUGBANK:DB14324

subject_name: Apricot kernel oil

object_name: Menopause present (finding)


subject: DRUGBANK:DB14324

object_name: Menopause


subject: DRUGBANK:DB14324

object_name: History of recurrent urinary tract infection


subject: DRUGBANK:DB14324

object_name: Recurrent urinary tract infections


subject: DRUGBANK:DB14324

object_name: postmenopausal atrophic vaginitis


subject: CHEBI:17741

subject_name: N,N-dimethylformamide

object_name: relapsing-remitting multiple sclerosis


subject: UMLS:C0892938

subject_name: OGT 918

object_name: Gaucher disease


subject: CHEBI:50381

subject_name: Miglustat


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Permanent atrial fibrillation


subject: UMLS:C5227816

object_name: insomnia


subject: UMLS:C5227816

object_name: Insomnia, CTCAE 3.0


subject: UMLS:C5227816

object_name: Insomnia, CTCAE 5.0


subject: UMLS:C5227816

object_name: endogenous depression


subject: CHEBI:228302

subject_name: Zuranolone


subject: CHEBI:228302


subject: CHEBI:228302


subject: CHEBI:228302


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Parkinson disease


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: UNII:LJA4M1L5LG

subject_name: Binodenoson

object_name: coronary artery disorder


subject: UNII:LJA4M1L5LG

object_name: coronary atherosclerosis


subject: UMLS:C4744361

subject_name: AKT Inhibitor

object_name: Advanced breast cancer


subject: UMLS:C4744361

object_name: Hormone receptor positive tumor


subject: UMLS:C4744361

object_name: breast neoplasm


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Her2-receptor negative breast cancer


subject: UNII:5S371K6132


subject: CHEBI:50790

subject_name: EC 1.14.14.14 (aromatase) inhibitor


subject: UMLS:C0593802

subject_name: Aromatase Inhibitors


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UNII:5ZHA5P4PFX

subject_name: Dalpiciclib


subject: UNII:5ZHA5P4PFX


subject: UNII:5ZHA5P4PFX


subject: UNII:768FW21J3L

subject_name: Famitinib


subject: UNII:768FW21J3L


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib


subject: UNII:TWF0ML1CK8

object_name: Childhood Breast Carcinoma


subject: UNII:TWF0ML1CK8

object_name: breast carcinoma


subject: UNII:TWF0ML1CK8

object_name: breast cancer


subject: UNII:TWF0ML1CK8


subject: UNII:TWF0ML1CK8


subject: UNII:TWF0ML1CK8


subject: CHEBI:5523

subject_name: Goserelin


subject: UMLS:C5908533

subject_name: PI3K Alpha Inhibitor


subject: UMLS:C5908533


subject: UMLS:C5908533


subject: UMLS:C5908533


subject: UMLS:C5908533


subject: UMLS:C5908533


subject: UMLS:C5908533


subject: UMLS:C5418043

subject_name: ADC SHR-A1811


subject: UMLS:C5418043


subject: UMLS:C5785765


subject: UMLS:C5785765


subject: UMLS:C5907971

subject_name: Anti-HER3 Antibody-drug Conjugate SHR-A2009


subject: UMLS:C5907971


subject: UMLS:C5854493

subject_name: Anti-nectin-4 Antibody-drug Conjugate SHR-A2102


subject: UMLS:C5854493


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2XD9773ZMN

subject_name: Tonabersat

object_name: diabetic macular edema


subject: CHEBI:32133

object_name: adult acute respiratory distress syndrome


subject: UNII:0CLL4232KD

subject_name: SIVELESTAT SODIUM

object_name: acute respiratory distress syndrome


subject: UNII:0CLL4232KD


subject: UMLS:C2699305

subject_name: Sivelestat Sodium


subject: UMLS:C2699305


subject: UMLS:C1250042

subject_name: oxytocin nasal spray

object_name: antisocial personality disorder


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: doxorubicin induced cardiomyopathy


subject: CHEBI:85078

object_name: Cardiomyopathy secondary to doxorubicin administration


subject: UMLS:C4743011

object_name: inflammatory bowel disease 1


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: dermatographia


subject: UMLS:C0910794


subject: UNII:OOA78Q9G2I

object_name: hypertension


subject: UNII:OOA78Q9G2I

object_name: Hypertension, CTCAE


subject: DRUGBANK:DB08937

object_name: squamous cell lung carcinoma


subject: CHEBI:90876

subject_name: Lonsurf


subject: UNII:7NL2E3F6K3

subject_name: Emicizumab

object_name: Haemophilic pseudotumour


subject: UMLS:C4726644

subject_name: PEGylated Recombinant Factor VIII

object_name: factor VIII measurement


subject: UMLS:C4083869

subject_name: Adynovate

object_name: hemophilia A


subject: UMLS:C4083869


subject: UMLS:C3834220

subject_name: Eloctate


subject: UMLS:C3834220


subject: UNII:7NL2E3F6K3


subject: PUBCHEM.COMPOUND:53477739

subject_name: Vasopressin

object_name: liver failure


subject: PUBCHEM.COMPOUND:11979316


subject: UMLS:C5966161

subject_name: Vasopressin (anatomical)


subject: CHEBI:8988

object_name: medulloblastoma


subject: CHEBI:8988

object_name: childhood medulloblastoma


subject: CHEBI:8988

object_name: adult medulloblastoma


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:232556

subject_name: Erdafitinib

object_name: Carcinoma breast stage IV


subject: UMLS:C5854389

subject_name: Ultra-micronized Palmitoyl Ethylamine (PEA) FSD-201


subject: CHEBI:6432

subject_name: Levamisole

object_name: liver carcinoma


subject: CHEBI:6432

object_name: Klatskin Tumor


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: Restenosis


subject: CHEBI:5931

subject_name: insulin human


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome


subject: PUBCHEM.COMPOUND:53477758

object_name: Adverse Event Associated with Cardiac Arrhythmia


subject: PUBCHEM.COMPOUND:53477758

object_name: Arrhythmia


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: UMLS:C0592155


subject: CHEBI:92511

subject_name: Ketotifen

object_name: Seasonal allergic conjunctivitis


subject: UNII:P93RUU11P7

subject_name: INOTUZUMAB

object_name: acute biphenotypic leukemia


subject: UNII:P93RUU11P7

object_name: mixed phenotype acute leukemia


subject: UNII:P93RUU11P7

object_name: acute leukemia of ambiguous lineage


subject: UNII:P93RUU11P7

object_name: testicular leukemia


subject: UNII:P93RUU11P7

object_name: central nervous system leukemia


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: CHEBI:52763

object_name: alcohol abuse


subject: CHEBI:52763

object_name: alcohol dependence


subject: CHEBI:16919

subject_name: Creatine

object_name: Nutritional status


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: follicular lymphoma


subject: UMLS:C3256182

subject_name: Sedum roseum root extract

object_name: Fatigue, CTCAE 5.0


subject: UMLS:C3256182

object_name: Fatigue


subject: CHEBI:64312

subject_name: Memantine

object_name: EXCESS LMW-DNA


subject: UMLS:C2348498

object_name: leukemia


subject: UMLS:C2348498

object_name: childhood leukemia


subject: UMLS:C2348498

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C2348498

object_name: Myelodysplasia


subject: UMLS:C2348498

object_name: Miller-Dieker lissencephaly syndrome


subject: UMLS:C2348498

object_name: myoclonic dystonia 11


subject: UMLS:C2348498

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C2348498

object_name: childhood myelodysplastic syndrome


subject: UMLS:C2348498

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:90217

subject_name: Quizartinib


subject: CHEBI:90217


subject: CHEBI:90217


subject: CHEBI:90217


subject: CHEBI:90217


subject: CHEBI:90217


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: acute lung injury


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Childhood Neuroblastoma


subject: CHEBI:63791

object_name: neuroblastoma


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: Non-small cell lung cancer stage I


subject: PUBCHEM.COMPOUND:368860

subject_name: Becatecarin

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:368860

object_name: lymphoma


subject: PUBCHEM.COMPOUND:368860

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:368860

object_name: unspecified childhood solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:368860

object_name: retinoblastoma


subject: PUBCHEM.COMPOUND:368860


subject: PUBCHEM.COMPOUND:368860


subject: PUBCHEM.COMPOUND:368860

object_name: malignant soft tissue neoplasm


subject: PUBCHEM.COMPOUND:368860

object_name: sarcoma


subject: UNII:CVN0S9V910

subject_name: MAL

object_name: superficial multifocal basal cell carcinoma


subject: CHEBI:15595


subject: CHEBI:28918

subject_name: Epinephrine


subject: CHEBI:28918

object_name: Bowen's Disease


subject: UMLS:C0338133

subject_name: Gemzar

object_name: pancreatic neoplasm


subject: UMLS:C0338133

object_name: exocrine pancreatic carcinoma


subject: UMLS:C0338133

object_name: malignant pancreatic neoplasm


subject: UMLS:C5854395

subject_name: HMBD 001

object_name: endometrial cancer


subject: UMLS:C5854395

object_name: uterine corpus cancer


subject: UMLS:C5854395

object_name: endometrial carcinoma


subject: UMLS:C5854395

object_name: cervical cancer


subject: UMLS:C5854395

object_name: cervical carcinoma


subject: UMLS:C5854395

object_name: bladder tumor


subject: UMLS:C5854395

object_name: urinary bladder carcinoma


subject: UMLS:C5854395

object_name: urinary bladder cancer


subject: UMLS:C5854395

object_name: childhood bladder carcinoma


subject: UMLS:C5854395

object_name: Stomach cancer


subject: UMLS:C5854395

object_name: gastric cancer


subject: UMLS:C5854395

object_name: ovarian cancer


subject: UMLS:C5854395

object_name: ovarian neoplasm


subject: UMLS:C5854395

object_name: ovarian carcinoma


subject: UMLS:C5854395

object_name: triple-negative breast carcinoma


subject: UMLS:C5854395

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5854395

object_name: esophageal cancer


subject: UMLS:C5854395

object_name: castration-resistant prostate carcinoma


subject: UMLS:C5854395

object_name: liver carcinoma


subject: UMLS:C5854395

object_name: melanoma


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: cervical cancer


subject: CHEBI:68534

object_name: cervical carcinoma


subject: CHEBI:68534

object_name: bladder tumor


subject: CHEBI:68534

object_name: urinary bladder carcinoma


subject: CHEBI:68534

object_name: urinary bladder cancer


subject: CHEBI:68534

object_name: childhood bladder carcinoma


subject: CHEBI:68534

object_name: Stomach cancer


subject: CHEBI:68534

object_name: gastric cancer


subject: CHEBI:68534

object_name: ovarian cancer


subject: CHEBI:68534

object_name: ovarian neoplasm


subject: CHEBI:68534

object_name: ovarian carcinoma


subject: CHEBI:68534

object_name: pancreatic neoplasm


subject: CHEBI:68534

object_name: exocrine pancreatic carcinoma


subject: CHEBI:68534

object_name: malignant pancreatic neoplasm


subject: CHEBI:68534

object_name: triple-negative breast carcinoma


subject: CHEBI:68534

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:68534

object_name: esophageal cancer


subject: CHEBI:68534

object_name: melanoma


subject: CHEBI:91591

subject_name: Pheniramine

object_name: respiratory tract infectious disorder


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib

object_name: chronic myelomonocytic leukemia


subject: CHEBI:3561

subject_name: Cetirizine

object_name: urticaria


subject: CHEBI:3561

object_name: reported urticaria (physical finding)


subject: CHEBI:3561

object_name: Urticaria, CTCAE


subject: MESH:D003487

subject_name: Cyanoacrylates

object_name: hypospadias


subject: MESH:D003487

object_name: Penile hypospadias


subject: CHEBI:30356

subject_name: isobutyl group


subject: CHEBI:30356


subject: CHEBI:17858

subject_name: oxiglutatione

object_name: Parkinson disease


subject: CHEBI:177535

subject_name: L-Glutathione (reduced)


subject: CHEBI:57925


subject: CHEBI:177258

subject_name: Cytidine 2',3'-cyclic phosphate


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: Refractory acute myeloid leukemia


subject: CHEBI:68646

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:68646

object_name: myelodysplastic syndrome with excess blasts-2


subject: CHEBI:68646

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:68646

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:68646

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:75832

subject_name: ferrous sulfate

object_name: Iron deficiency without anemia


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: malignant glioma


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: cataract


subject: CHEBI:4466

object_name: Cataract, CTCAE 3.0


subject: CHEBI:4466

object_name: Cataract, CTCAE 5.0


subject: CHEBI:4466

object_name: cataract on exam (physical finding)


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UMLS:C3854029

subject_name: antiseptics ethanol

object_name: Clinical infection


subject: UMLS:C3854030

subject_name: CNS depressants ethanol


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Stage IV Nasopharyngeal Carcinoma


subject: GTOPDB:12989

subject_name: toripalimab


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: CHEBI:87631

subject_name: statin

object_name: hepatitis C


subject: CHEBI:87631

object_name: chronic hepatitis C virus infection


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:9150


subject: UMLS:C3853872

subject_name: electrolyte solution

object_name: Sepsis


subject: UMLS:C3853872

object_name: Sepsis, CTCAE


subject: UMLS:C3853872

object_name: liver cirrhosis


subject: UMLS:C3853872

object_name: Acute-On-Chronic Liver Failure


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib

object_name: skin melanoma


subject: PUBCHEM.COMPOUND:51038893

object_name: stage, melanoma


subject: CHEBI:63637

subject_name: Vemurafenib


subject: CHEBI:63637


subject: UNII:O43472U9X8

subject_name: Obinutuzumab

object_name: chronic graft versus host disease


subject: UMLS:C1522569

subject_name: Interleukin-15, human recombinant

object_name: leukemia


subject: UMLS:C1522569

object_name: childhood leukemia


subject: UMLS:C1522569


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: primary central nervous system lymphoma


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: traumatic encephalopathy


subject: CHEBI:6887

object_name: traumatic brain injury


subject: CHEBI:36704

subject_name: Imiquimod

object_name: male breast carcinoma


subject: CHEBI:36704

object_name: Secondary malignant neoplasm of skin


subject: CHEBI:36704

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:36704

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:36704

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: Childhood Malignant Solid Neoplasm


subject: CHEBI:90001

object_name: Malignant Solid Neoplasm


subject: CHEBI:28082


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: UMLS:C3813556


subject: PR:000050337

subject_name: mature calcitonin


subject: PR:000050337


subject: CHEBI:95165

object_name: Acute lymphoblastic leukemia, in relapse


subject: CHEBI:95165

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:95165

object_name: Lymphoblastic lymphoma (Precursor B-lymphoblastic lymphoma/leukaemia) refractory


subject: CHEBI:95165

object_name: Lymphoblastic lymphoma (Precursor T-lymphoblastic lymphoma/leukaemia) refractory


subject: CHEBI:95165

object_name: Lymphoblastic lymphoma (Precursor T-lymphoblastic lymphoma/leukaemia) recurrent


subject: CHEBI:95165

object_name: Lymphoblastic lymphoma (Precursor B-lymphoblastic lymphoma/leukaemia) recurrent


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:131174

subject_name: Navitoclax


subject: CHEBI:131174


subject: CHEBI:131174


subject: CHEBI:131174


subject: CHEBI:131174


subject: CHEBI:131174


subject: PUBCHEM.COMPOUND:91973920

subject_name: Grape Seed P.E.

object_name: abdominal obesity-metabolic syndrome


subject: PUBCHEM.COMPOUND:91973920

object_name: metabolic syndrome X


subject: MESH:D056604

subject_name: Grape Seed Extract


subject: MESH:D056604


subject: DRUGBANK:DB16606

subject_name: Vitis vinifera seed


subject: DRUGBANK:DB16606


subject: UMLS:C1616858

subject_name: INJECTION, APOMORPHINE HYDROCHLORIDE, 1 MG ADMINISTERED

object_name: Parkinson disease


subject: UMLS:C2711995

object_name: acute myeloid leukemia


subject: CHEBI:94807

subject_name: Nitazoxanide

object_name: sexually transmitted disease


subject: CHEBI:7986

subject_name: Pentoxifylline


subject: UMLS:C5203530

subject_name: Tranexamic Acid Liquid Injection

object_name: Metastatic malignant neoplasm to bone


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: MESH:C577048

object_name: type 2 diabetes mellitus


subject: UMLS:C5236062

subject_name: Multi-mode Kinase Inhibitor EOC317

object_name: Childhood Solid Neoplasm


subject: UMLS:C5236062

object_name: Adult Solid Neoplasm


subject: UMLS:C5236062

object_name: Solid Neoplasm


subject: UMLS:C2683450

subject_name: SYMPT-X Glutamine

object_name: Cachexia


subject: UMLS:C2683450

object_name: disorder of glutamine metabolism


subject: UNII:EB87433V6F

object_name: benign female reproductive system neoplasm


subject: PUBCHEM.COMPOUND:21982135


subject: CHEBI:73038

subject_name: Parecoxib


subject: UMLS:C0021741

subject_name: Actimmune

object_name: Chronic small plaque psoriasis


subject: GTOPDB:13796

subject_name: serplulimab

object_name: gastric adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594550

subject_name: SERPLULIMAB


subject: UMLS:C4745029

subject_name: HLX 10


subject: PR:000013574

subject_name: sulfhydryl oxidase 1


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Left ventricular hypertrophy


subject: PUBCHEM.COMPOUND:73151030

object_name: Left Ventricular Hypertrophy by ECG Finding


subject: PUBCHEM.COMPOUND:172866837

subject_name: Enlicitide Decanoate

object_name: hypercholesterolemia, familial, 1


subject: PUBCHEM.COMPOUND:172866837

object_name: familial hypercholesterolemia


subject: UNII:PSR59MCX5M

subject_name: ENLICITIDE DECANOATE


subject: UNII:PSR59MCX5M


subject: CHEBI:5494

subject_name: ritropirronium bromide

object_name: Nausea, CTCAE_5


subject: CHEBI:5494

object_name: Nausea


subject: CHEBI:5494

object_name: Nausea, CTCAE_3


subject: CHEBI:5494

object_name: Vomiting, CTCAE


subject: CHEBI:5494

object_name: Vomiting


subject: CHEBI:94449

subject_name: Glycopyrronium


subject: CHEBI:94449


subject: CHEBI:94449


subject: CHEBI:94449


subject: CHEBI:94449


subject: UMLS:C5959678

subject_name: PI3K-alpha Inhibitor JS105

object_name: Childhood Breast Carcinoma


subject: UMLS:C5959678

object_name: breast carcinoma


subject: UMLS:C5959678

object_name: breast cancer


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Adult Giant Cell Glioblastoma


subject: UNII:2S9ZZM9Q9V

object_name: Childhood Giant Cell Glioblastoma


subject: UNII:2S9ZZM9Q9V

object_name: giant cell glioblastoma


subject: UNII:2S9ZZM9Q9V

object_name: Small cell glioblastoma


subject: UMLS:C0064332

subject_name: keyhole-limpet hemocyanin

object_name: glioblastoma


subject: UMLS:C0064332

object_name: Childhood Glioblastoma


subject: UMLS:C0064332

object_name: adult glioblastoma


subject: UMLS:C0064332

object_name: Recurrent Childhood Glioblastoma


subject: UMLS:C0064332

object_name: Recurrent Glioblastoma


subject: UMLS:C0064332


subject: UMLS:C0064332


subject: UMLS:C0064332


subject: UMLS:C0064332


subject: UMLS:C0064332

object_name: Adult Gliosarcoma


subject: UMLS:C0064332

object_name: gliosarcoma


subject: UMLS:C0064332

object_name: Childhood Gliosarcoma


subject: CHEMBL.COMPOUND:CHEMBL2107863

subject_name: RINDOPEPIMUT


subject: CHEMBL.COMPOUND:CHEMBL2107863


subject: CHEMBL.COMPOUND:CHEMBL2107863


subject: CHEMBL.COMPOUND:CHEMBL2107863


subject: CHEMBL.COMPOUND:CHEMBL2107863


subject: CHEMBL.COMPOUND:CHEMBL2107863


subject: CHEMBL.COMPOUND:CHEMBL2107863


subject: CHEMBL.COMPOUND:CHEMBL2107863


subject: CHEMBL.COMPOUND:CHEMBL2107863


subject: CHEMBL.COMPOUND:CHEMBL2107863


subject: CHEMBL.COMPOUND:CHEMBL2107863


subject: CHEMBL.COMPOUND:CHEMBL2107863


subject: UMLS:C3181262

subject_name: rindopepimut


subject: UMLS:C3181262


subject: UMLS:C3181262


subject: UMLS:C3181262


subject: UMLS:C3181262


subject: UMLS:C3181262


subject: UMLS:C3181262


subject: UMLS:C3181262


subject: UMLS:C3181262


subject: UMLS:C3181262


subject: UMLS:C3181262


subject: UMLS:C3181262


subject: UMLS:C3181263

subject_name: CDX 110


subject: UMLS:C3181263


subject: UMLS:C3181263


subject: UMLS:C3181263


subject: UMLS:C3181263


subject: UMLS:C3181263


subject: UMLS:C3181263


subject: UMLS:C3181263


subject: UMLS:C3181263


subject: UMLS:C3181263


subject: UMLS:C3181263


subject: UMLS:C3181263


subject: CHEBI:139072

object_name: Fibromyalgia, Primary


subject: CHEBI:8614

subject_name: Psilocybin


subject: UNII:QQA9MLH692

subject_name: Tafasitamab

object_name: adult lymphoma


subject: UNII:QQA9MLH692

object_name: lymphoma


subject: UNII:QQA9MLH692

object_name: pediatric lymphoma


subject: UMLS:C2987409


subject: UMLS:C2987409


subject: UMLS:C2987409


subject: CHEBI:95341

subject_name: Baricitinib

object_name: cardiac sarcoidosis


subject: UMLS:C4045875


subject: UMLS:C0114857

subject_name: Dotarem

object_name: interstitial lung disease


subject: UMLS:C4763760

subject_name: Gallium Ga 68 NODAGA-CBP8


subject: CHEBI:64212

subject_name: Exisulind

object_name: non-small cell lung carcinoma


subject: CHEBI:63577

subject_name: Lamivudine

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:7575

subject_name: Nimodipine

object_name: Presenile dementia


subject: CHEBI:7575

object_name: dementia


subject: UMLS:C0219461

subject_name: regramostim

object_name: familial acute respiratory distress syndrome, ANLN-related, dog


subject: UMLS:C0219461

object_name: acute respiratory distress syndrome


subject: UMLS:C0219461

object_name: COVID-19-Associated Acute Respiratory Distress Syndrome


subject: UMLS:C0219461

object_name: adult acute respiratory distress syndrome


subject: UNII:63P7W7886U

object_name: HIV infection


subject: CHEBI:135515

subject_name: Bendamustine

object_name: grade 3A follicular lymphoma


subject: CHEBI:135515

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:135515

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: CHEBI:135515

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:135515

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:135515

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: CHEBI:135515

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: CHEBI:52717

subject_name: Bortezomib


subject: CHEBI:28887

subject_name: Ofatumumab


subject: CHEBI:28887


subject: CHEBI:28887


subject: CHEBI:28887


subject: CHEBI:28887


subject: CHEBI:28887


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: lupus nephritis


subject: MESH:C050102

subject_name: measles, mumps, rubella, varicella vaccine

object_name: meningococcal infection


subject: UNII:DHT6E8M4KP

subject_name: Pelitrexol

object_name: colorectal neoplasm


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: Endometriosis of pelvis


subject: PUBCHEM.COMPOUND:6096882

object_name: Endometriosis outside pelvis


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: CHEBI:6030

subject_name: Isoniazid

object_name: AIDS


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: CHEBI:4877

subject_name: Ethambutol


subject: CHEBI:4877


subject: CHEBI:45285

subject_name: Pyrazinamide


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: UMLS:C1268859

subject_name: Zinc supplement

object_name: diarrhea


subject: UMLS:C1268859

object_name: rectal discharge diarrhea (physical finding)


subject: UMLS:C1268859

object_name: Diarrhea, CTCAE


subject: UMLS:C1268859

object_name: Antibiotic-associated diarrhea


subject: UMLS:C2719312

subject_name: Embeda

object_name: Episodic nondependent harmful pattern of use of opioid


subject: CHEBI:50731

subject_name: morphine sulfate pentahydrate


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:7465

subject_name: Naltrexone


subject: CHEBI:41977

subject_name: Daunorubicin

object_name: Childhood Breast Carcinoma


subject: CHEBI:41977

object_name: breast carcinoma


subject: CHEBI:41977

object_name: breast cancer


subject: UNII:3DGD69C6PV

subject_name: brigatinib

object_name: inflammatory myofibroblastic tumor


subject: UMLS:C4279708

object_name: Low back pain


subject: UMLS:C4279708

object_name: pain agnosia


subject: UMLS:C4279708

object_name: Pain insensitivity


subject: UMLS:C4279708

object_name: chronic pain (diagnosis)


subject: UMLS:C4279708

object_name: Chronic pain


subject: CHEBI:8764

subject_name: Mycophenolate mofetil

object_name: Takayasu arteritis


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: CHEBI:44185

subject_name: Methotrexate


subject: UniProtKB:P47802

subject_name: MTX1_MOUSE Metaxin-1 (sprot)


subject: PR:000010755


subject: CHEBI:32599

object_name: Asthmatic bronchitis


subject: CHEBI:15414

subject_name: Adomet

object_name: sclerosing cholangitis


subject: CHEBI:67040

subject_name: Ademetionine


subject: CHEBI:174428


subject: RXCUI:1945037

subject_name: fluticasone / umeclidinium / vilanterol Dry Powder Inhaler

object_name: Chronic obstructive pulmonary disease of horses


subject: RXCUI:1945037

object_name: COPD, severe early onset


subject: RXCUI:1945037

object_name: chronic obstructive pulmonary disease


subject: RXCUI:1487516

subject_name: umeclidinium / vilanterol Inhalant Product


subject: RXCUI:1487516


subject: RXCUI:1487516


subject: CHEBI:194425

subject_name: Lobaplatin

object_name: Nasopharyngeal cancer recurrent


subject: CHEMBL.COMPOUND:CHEMBL2068623


subject: CHEBI:192744

subject_name: lobaplatin


subject: CHEBI:32599

object_name: hypotension


subject: CHEBI:32599

object_name: Hypotension, CTCAE


subject: CHEBI:17202

subject_name: Inosinic Acid

object_name: multiple system atrophy


subject: UNII:7KKS9R192F

subject_name: Gimatecan

object_name: small cell lung carcinoma


subject: UMLS:C4764365

subject_name: Patidegib Topical Gel

object_name: Recurrent basal cell carcinoma


subject: CHEBI:4974

subject_name: Famciclovir

object_name: herpes simplex dermatitis


subject: CHEBI:4974

object_name: Herpes NOS


subject: UMLS:C0813973

subject_name: Medical Marijuana

object_name: Tourette syndrome


subject: UNII:BU8V88OWIQ

subject_name: Sodium hydrogen sulfate

object_name: ovarian carcinoma


subject: UNII:BU8V88OWIQ

object_name: malignant epithelial tumor of ovary


subject: UNII:BU8V88OWIQ

object_name: Acute kidney injury due to circulatory failure


subject: CHEBI:32149

subject_name: Sodium sulfate


subject: CHEBI:32149


subject: CHEBI:32149


subject: CHEBI:9168

subject_name: Sirolimus

object_name: classic familial adenomatous polyposis


subject: CHEBI:9168

object_name: Adenomatous colonic polyposis


subject: MESH:C505143

subject_name: Boostrix

object_name: tetanus


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Overweight and obesity


subject: UMLS:C0592155

subject_name: Syntocinon


subject: CHEBI:4911

subject_name: Etoposide

object_name: neuroendocrine neoplasm


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:31355

subject_name: Carboplatin

object_name: neuroendocrine carcinoma


subject: CHEBI:31355


subject: CHEBI:8024

subject_name: Perindopril

object_name: Diabetes


subject: CHEBI:8024

object_name: diabetes mellitus


subject: CHEBI:8024

object_name: Moderate albuminuria


subject: CHEBI:75998

subject_name: Trametinib

object_name: primary interstitial lung disease specific to childhood


subject: CHEBI:75998

object_name: interstitial lung disease specific to childhood


subject: CHEBI:75998

object_name: plexiform neurofibroma


subject: CHEBI:188719

subject_name: Ertugliflozin

object_name: Liver Fibrosis


subject: CHEBI:188719

object_name: Fatty Liver


subject: CHEBI:188719

object_name: Weight Change


subject: CHEBI:188719

object_name: Immune Tolerance


subject: CHEBI:188719

object_name: Drug Tolerance


subject: CHEBI:15551

subject_name: Dinoprostone

object_name: Vaginal delivery (finding)


subject: CHEBI:15551

object_name: previous vaginal delivery (history)


subject: CHEBI:8869

subject_name: Risedronic acid

object_name: Colles' Fracture


subject: DRUGBANK:DB16537

subject_name: Bacillus clausii

object_name: urinary tract infection


subject: DRUGBANK:DB16537

object_name: bacterial urinary tract infection


subject: DRUGBANK:DB16537

object_name: Urinary Tract Infection, CTCAE


subject: DRUGBANK:DB16537

object_name: Catheter related bloodstream infection


subject: DRUGBANK:DB16537

object_name: diarrhea


subject: DRUGBANK:DB16537

object_name: rectal discharge diarrhea (physical finding)


subject: DRUGBANK:DB16537

object_name: Diarrhea, CTCAE


subject: UMLS:C4721965

subject_name: Histone Deacetylase Inhibitor VRx-3996

object_name: lymphoproliferative syndrome


subject: UNII:40P3287I94

subject_name: Trestolone

object_name: Blood Pressure Finding


subject: UNII:40P3287I94

object_name: Systemic arterial pressure


subject: PR:000060164

subject_name: protein MENT


subject: PR:000060164


subject: CHEBI:6541

subject_name: Losartan

object_name: eosinophilic esophagitis


subject: CHEBI:6541

object_name: Eosinophilic infiltration of the esophagus


subject: CHEBI:6541

object_name: connective tissue disorder


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: Helicobacter pylori [H. pylori] infection in conditions classified elsewhere and of unspecified site


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: congenital pulmonary veins atresia or stenosis


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: CHEBI:46726

subject_name: magnetite


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: plasma cell leukemia


subject: UMLS:C0003442

object_name: lymphoplasmacytic lymphoma


subject: UMLS:C0003442

object_name: mantle cell lymphoma


subject: UMLS:C0003442

object_name: follicular lymphoma


subject: CHEBI:40279

subject_name: Allopurinol

object_name: hematologic disorder


subject: CHEBI:40279

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:40279

object_name: acute lymphoblastic leukemia


subject: CHEBI:40279


subject: CHEBI:40279


subject: CHEBI:40279

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:40279


subject: CHEBI:40279

object_name: prolymphocytic leukemia


subject: CHEBI:40279

object_name: lymphoblastic lymphoma


subject: CHEBI:40279

object_name: Adult Lymphoblastic Lymphoma


subject: CHEBI:40279

object_name: Childhood Lymphoblastic Lymphoma


subject: CHEBI:40279

object_name: B-cell non-Hodgkin lymphoma


subject: CHEBI:40279

object_name: B-cell neoplasm


subject: CHEBI:40279


subject: CHEBI:40279

object_name: non-Hodgkin lymphoma


subject: CHEBI:40279

object_name: Burkitt lymphoma


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: CHEBI:167450


subject: CHEBI:167450


subject: CHEBI:167450


subject: CHEBI:167450


subject: UMLS:C0163712

subject_name: Relate - vinyl resin


subject: UMLS:C0163712


subject: UMLS:C0163712

object_name: acute myeloid leukemia


subject: UMLS:C0163712

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C0163712

object_name: Myelodysplasia


subject: UMLS:C0163712


subject: UMLS:C0163712

object_name: plasma cell leukemia


subject: UMLS:C0163712

object_name: lymphoplasmacytic lymphoma


subject: UMLS:C0163712


subject: UMLS:C0163712

object_name: mantle cell lymphoma


subject: UMLS:C0163712


subject: UMLS:C0163712

object_name: plasma cell myeloma


subject: UMLS:C0163712


subject: UMLS:C0163712


subject: UMLS:C0163712


subject: UMLS:C0163712


subject: UMLS:C0163712


subject: UMLS:C0163712

object_name: follicular lymphoma


subject: UMLS:C0163712


subject: UMLS:C0163712


subject: CHEBI:67272

subject_name: Perifosine


subject: CHEBI:7514

subject_name: Neostigmine

object_name: Neuromuscular inhibition


subject: CHEBI:7514

object_name: Neuromuscular block, function


subject: CHEBI:7514

object_name: Nervous System Finding


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: bladder carcinoma in situ


subject: UNII:28X28X9OKV

object_name: Stage 0is Bladder Cancer AJCC v8


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: GTOPDB:10492

subject_name: envafolimab

object_name: Non-small cell lung cancer stage III


subject: UNII:ES1M06M6QH


subject: UMLS:C4329339


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol

object_name: Fatigue, CTCAE 5.0


subject: PUBCHEM.COMPOUND:3080587

object_name: Fatigue


subject: PUBCHEM.COMPOUND:24748496

subject_name: Allisartan isoproxil

object_name: essential hypertension


subject: UNII:DI4662MK4N

subject_name: ALLISARTAN ISOPROXIL


subject: MESH:D008383

subject_name: Margarine

object_name: hyperlipidemia


subject: MESH:D008383

object_name: hyperlipoproteinemia


subject: MESH:D008383

object_name: Hyperlipidemia, CTCAE


subject: MESH:D008383

object_name: Serum lipids high (finding)


subject: CHEBI:151315

subject_name: Heparin

object_name: Smoke Inhalation Injury


subject: KEGG.COMPOUND:C00374


subject: UMLS:C5400059

object_name: small cell lung carcinoma


subject: UMLS:C4723695

subject_name: penpulimab

object_name: Breast neoplasm female


subject: UMLS:C5207052

subject_name: Paclitaxel Albumin


subject: UMLS:C3827032

subject_name: Catequentinib Hydrochloride


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: Trismus


subject: CHEBI:5855

object_name: Trismus, CTCAE


subject: CHEBI:5855

object_name: Inflammatory Response


subject: CHEBI:5855

object_name: Impacted tooth


subject: CHEBI:188074

object_name: Inflammation


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: UMLS:C3827082

object_name: anus cancer


subject: UMLS:C3827082

object_name: anal carcinoma


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: breast neoplasm


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: inflammatory bowel disease 1


subject: CHEBI:16991

subject_name: DNA

object_name: Unresectable Hepatocellular Carcinoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Tubular breast cancer stage II


subject: CHEBI:4026

object_name: invasive ductal breast carcinoma


subject: CHEBI:4026

object_name: Mucinous breast cancer stage II


subject: CHEBI:4026

object_name: Tubular breast cancer stage III


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: HER2 positive breast carcinoma


subject: UNII:4EQZ6YO2HI

object_name: inflammatory breast carcinoma


subject: UNII:4EQZ6YO2HI

object_name: Malignant neoplasm of female breast


subject: UNII:4EQZ6YO2HI


subject: UNII:4EQZ6YO2HI


subject: UNII:4EQZ6YO2HI


subject: UNII:4EQZ6YO2HI


subject: UMLS:C1530450

subject_name: AMG 162


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: CHEBI:47898

subject_name: Epirubicin


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:47898


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: PUBCHEM.COMPOUND:11979316

subject_name: Vasopressin

object_name: pulmonary hypertension


subject: PUBCHEM.COMPOUND:70789201

subject_name: Telithromycin

object_name: Community-Acquired Pneumonia


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Myocardial Reperfusion Injury


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: Left atrial appendage thrombosis


subject: PUBCHEM.COMPOUND:53328043

subject_name: Iberdomide

object_name: smoldering plasma cell myeloma


subject: UMLS:C0301158

subject_name: Phthalocyanine dye

object_name: periodontitis


subject: UMLS:C0301158

object_name: Atrophy of alveolar ridges


subject: CHEBI:6931

subject_name: Midazolam

object_name: Aggressive behavior


subject: CHEBI:6931

object_name: Aggression


subject: CHEBI:6931

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:6931

object_name: Fatigue


subject: CHEBI:6015

subject_name: Isoflurane

object_name: subarachnoid hemorrhage


subject: CHEBI:6015

object_name: stroke disorder


subject: CHEBI:6015

object_name: cerebrovascular disorder


subject: CHEBI:6015

object_name: Stroke (heart beat)


subject: CHEBI:6015

object_name: Stroke, CTCAE


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: cerebral cavernous malformation


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: male breast carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Carcinoma breast stage IV


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Breast cancer recurrent


subject: DRUGBANK:DB05801


subject: DRUGBANK:DB05801


subject: DRUGBANK:DB05801


subject: DRUGBANK:DB05801


subject: DRUGBANK:DB05801


subject: DRUGBANK:DB05801


subject: CHEBI:3125

subject_name: Bisacodyl

object_name: Functional constipation


subject: CHEBI:3125

object_name: Irritable bowel syndrome characterized by constipation


subject: PUBCHEM.COMPOUND:160883

subject_name: Butylscopolamine


subject: PUBCHEM.COMPOUND:160883


subject: UMLS:C2983738

subject_name: Adenovirus-p53 Transduced Dendritic Cell Vaccine

object_name: Childhood Breast Carcinoma


subject: UMLS:C2983738

object_name: breast carcinoma


subject: UMLS:C2983738

object_name: breast cancer


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: digestive system cancer


subject: UNII:2S9ZZM9Q9V

object_name: Malignant ascites


subject: DRUGBANK:DB16549

subject_name: Bifidobacterium breve

object_name: celiac disease


subject: PUBCHEM.COMPOUND:71300755

subject_name: Serelaxin

object_name: Acute Heart Failure Related to COVID-19


subject: PUBCHEM.COMPOUND:71300755

object_name: Acute heart failure


subject: UNII:W0122B976Y

subject_name: SERELAXIN


subject: UNII:W0122B976Y


subject: UNII:83RK89YQ7Y

object_name: congenital pseudoarthrosis of the tibia


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Non-Muscle Invasive Bladder Urothelial Carcinoma


subject: CHEBI:41001

subject_name: Benzoylecgonine


subject: PUBCHEM.COMPOUND:251912

subject_name: Benzoyl ecgonine


subject: UMLS:C2698319

subject_name: Bacillus Calmette-Guerin Antigen


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: PR:000002994

subject_name: natural resistance-associated macrophage protein 1


subject: UNII:3110E3AO8S

subject_name: Basimglurant

object_name: tuberous sclerosis


subject: UNII:3110E3AO8S

object_name: situs inversus


subject: UNII:3110E3AO8S

object_name: tuberous sclerosis 1


subject: CHEBI:173554

subject_name: Ethyl 3-mercaptopropanoic acid

object_name: focal epilepsy


subject: CHEBI:9586

subject_name: Tiagabine


subject: UMLS:C5439908


subject: UMLS:C0722911

subject_name: Purinethol

object_name: acute lymphoblastic leukemia


subject: UMLS:C3827179

subject_name: Xaluprine


subject: UMLS:C1765313

subject_name: Atrasentan Hydrochloride

object_name: prostate carcinoma


subject: UMLS:C1765313

object_name: prostate cancer


subject: CHEBI:135609

subject_name: Gusperimus

object_name: granulomatosis with polyangiitis


subject: UMLS:C3540778

subject_name: Glucocorticoid inhalants for obstructive airway disease


subject: CHEBI:24261

subject_name: glucocorticoid


subject: UMLS:C3540777

subject_name: Glucocorticoids, Systemic


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: stillborn caesarean section


subject: CHEBI:119915

subject_name: Fentanyl


subject: CHEBI:6149

subject_name: Levobupivacaine


subject: CHEBI:60802

subject_name: ropivacaine


subject: CHEBI:17515

subject_name: gamma-Glutamylcysteine

object_name: Parkinson disease


subject: UMLS:C0061060

subject_name: gamma-glutamylcysteine


subject: CHEBI:15843

subject_name: Arachidonate

object_name: Premature birth


subject: CHEBI:195181

subject_name: Alanylalanine


subject: UMLS:C0002520

subject_name: Amino Acids


subject: UMLS:C2346822

subject_name: conatumumab

object_name: pancreatic neoplasm


subject: UMLS:C2346822

object_name: exocrine pancreatic carcinoma


subject: UMLS:C2346822

object_name: malignant pancreatic neoplasm


subject: UMLS:C2346822

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C2346822

object_name: pancreatic adenocarcinoma


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug

object_name: Irvine-Gass Syndrome


subject: CHEBI:35475

object_name: Cystoid macular edema following cataract surgery


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C0003211


subject: UMLS:C3536840

subject_name: Nonsteroidal Anti-inflammatory Drug [EPC]


subject: UMLS:C3536840


subject: CHEBI:8060

subject_name: Phenelzine

object_name: Carcinoma breast stage IV


subject: UNII:9AG41L3AOQ

subject_name: Gallium-68 PSMA

object_name: High risk of


subject: UNII:9AG41L3AOQ

object_name: High risk


subject: UNII:9AG41L3AOQ

object_name: American College of Cardiology/American Heart Association Lesion Complexity Score C


subject: UNII:9AG41L3AOQ

object_name: High Risk Acute Leukemia


subject: UNII:9AG41L3AOQ

object_name: International Prognostic Index High Risk Group


subject: CHEBI:27732

subject_name: Caffeine

object_name: infectious disease


subject: CHEBI:91950


subject: CHEBI:3697

subject_name: Cilastatin


subject: UMLS:C3253517


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Headache, CTCAE


subject: CHEBI:63115

subject_name: Fingolimod

object_name: kidney failure


subject: UMLS:C0388088


subject: CHEBI:9150

subject_name: Simvastatin

object_name: osteoporosis


subject: CHEBI:9150

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:9150

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:9150

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:9150

object_name: spinal cord injury


subject: CHEBI:32181

subject_name: Tamibarotene

object_name: lupus nephritis


subject: UMLS:C4289970

subject_name: Anti-PD1 Monoclonal Antibody

object_name: extranodal nasal NK/T cell lymphoma


subject: CHEBI:133146

subject_name: Phe-Ala

object_name: Disorder of retina caused by radiation


subject: CHEBI:39002

subject_name: perfluoroadamantane


subject: CHEBI:29013

subject_name: Fusidic acid


subject: CHEBI:27470

subject_name: Folic acid


subject: UMLS:C3273039

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C3273039

object_name: non-Hodgkin lymphoma


subject: RXCUI:8375

subject_name: placebo Oral Tablet

object_name: type 2 diabetes mellitus


subject: UMLS:C5565869

object_name: intracerebral hemorrhage


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: Pseudogout


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: squamous cell carcinoma of penis


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:78543

subject_name: Ponatinib

object_name: endometrium neoplasm


subject: CHEBI:6015

subject_name: Isoflurane

object_name: Hematoma, Subdural, Acute


subject: CHEBI:44915

subject_name: Propofol


subject: PUBCHEM.COMPOUND:58291210

subject_name: Oligofructose

object_name: Overweight


subject: MESH:C120489

subject_name: oligofructose


subject: CHEBI:66964

subject_name: Dronabinol

object_name: Pain Threshold


subject: UMLS:C5854375

subject_name: Modified Interleukin-2 LTC004

object_name: pancreatic neoplasm


subject: UMLS:C5854375

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5854375

object_name: malignant pancreatic neoplasm


subject: UMLS:C5417813

subject_name: Fc-engineered Anti-CD40 Agonist Antibody 2141-V11


subject: UMLS:C5417813


subject: UMLS:C5417813


subject: MESH:C568705

subject_name: influvac

object_name: coronary artery disorder


subject: MESH:C568705

object_name: coronary atherosclerosis


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: CHEBI:66919


subject: CHEBI:9434

subject_name: Telmisartan

object_name: hyperlipidemia


subject: CHEBI:9434

object_name: hyperlipoproteinemia


subject: CHEBI:9434

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:9434

object_name: Serum lipids high (finding)


subject: CHEBI:5959

subject_name: Irbesartan

object_name: preeclampsia


subject: CHEBI:5959

object_name: hypertension, pregnancy-induced


subject: PUBCHEM.COMPOUND:135483998

object_name: attention deficit hyperactivity disorder, inattentive type


subject: PUBCHEM.COMPOUND:135483998


subject: CHEBI:136009

subject_name: L-Methylfolate


subject: CHEBI:136009


subject: CHEBI:53612

subject_name: Squaric acid dibutyl ester

object_name: large congenital melanocytic nevus


subject: UNII:41WC0AZ27V

object_name: Atopic rhinitis


subject: UNII:41WC0AZ27V

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:51209

subject_name: Pseudoephedrine


subject: UNII:W9Y8L7GP4C

subject_name: Cetrotide

object_name: infertility


subject: CHEBI:8884

subject_name: Rocuronium

object_name: chronic kidney disease


subject: CHEBI:8884

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:8884

object_name: intestinal obstruction


subject: CHEBI:8884

object_name: prostate carcinoma


subject: CHEBI:8884

object_name: prostate cancer


subject: CHEBI:8884

object_name: Uterine prolapse without mention of vaginal wall prolapse


subject: CHEBI:8884

object_name: Uterine prolapse


subject: CHEBI:8884

object_name: endometriosis


subject: CHEBI:8884

object_name: cholecystitis


subject: CHEBI:8884

object_name: Cholecystitis, CTCAE 3.0


subject: CHEBI:8884

object_name: Cholecystitis, CTCAE 5.0


subject: CHEBI:8884

object_name: uterine fibroid


subject: CHEBI:8884

object_name: leiomyoma


subject: UNII:7M9GZF9VTT

object_name: type 1 diabetes mellitus 1


subject: UNII:7M9GZF9VTT

object_name: type 1 diabetes mellitus


subject: UNII:P050J5FWC5

subject_name: INTERFERON GAMMA


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: desmoplastic small round cell tumor


subject: CHEBI:72564

subject_name: Temozolomide


subject: UMLS:C5691182

object_name: COPD, severe early onset


subject: UMLS:C5206571

subject_name: HPV16 E7-specific HLA-A*02:01-restricted IgG1-Fc Fusion Protein CUE-101

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5206571

object_name: Locally Advanced Malignant Neoplasm


subject: UMLS:C5206571

object_name: HPV positive oropharyngeal squamous cell carcinoma


subject: UMLS:C5206571

object_name: New diagnosis tumor


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: CHEBI:567361

subject_name: Cladribine

object_name: myeloproliferative neoplasm


subject: CHEBI:567361

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:567361

object_name: Blast Phase


subject: CHEBI:567361

object_name: myeloid sarcoma


subject: CHEBI:567361

object_name: Blasts 10 Percent or More of Bone Marrow Nucleated Cells


subject: CHEBI:567361

object_name: Philadelphia Chromosome Positive


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:50223

subject_name: Dexrazoxane


subject: CHEBI:50223


subject: CHEBI:50223

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:50223

object_name: acute myeloid leukemia


subject: CHEBI:50223

object_name: High Risk Myelodysplastic Syndrome


subject: CHEBI:50223


subject: CHEBI:50223


subject: CHEBI:50223


subject: UNII:8GZG754X6M

subject_name: Gemtuzumab


subject: UNII:8GZG754X6M


subject: UNII:8GZG754X6M


subject: UNII:8GZG754X6M


subject: UNII:8GZG754X6M


subject: UNII:8GZG754X6M


subject: UNII:8GZG754X6M


subject: UMLS:C0677800

subject_name: CMA 676


subject: UMLS:C0677800


subject: UMLS:C0677800


subject: UMLS:C0677800


subject: UMLS:C0677800


subject: UMLS:C0677800


subject: UMLS:C0677800


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42068


subject: CHEBI:42068


subject: UNII:FU88PI0433

subject_name: ARZOXIFENE HYDROCHLORIDE

object_name: endometrial cancer


subject: UNII:FU88PI0433

object_name: uterine corpus cancer


subject: UNII:FU88PI0433

object_name: endometrial carcinoma


subject: UMLS:C1527089

subject_name: Arzoxifene Hydrochloride


subject: UMLS:C1527089


subject: UMLS:C1527089


subject: UMLS:C4683552

object_name: Multiple malignancy


subject: CHEBI:94366

subject_name: itraconazole


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: CHEBI:114785

subject_name: Erlotinib

object_name: glioblastoma


subject: CHEBI:114785

object_name: Childhood Glioblastoma


subject: CHEBI:114785

object_name: gliosarcoma


subject: CHEBI:114785

object_name: Childhood Gliosarcoma


subject: CHEBI:70839

subject_name: Dasatinib


subject: CHEBI:70839


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: UMLS:C4764331

object_name: bladder transitional cell carcinoma


subject: UMLS:C4764331

object_name: transitional cell carcinoma


subject: CHEBI:144613

subject_name: Pro-Glu-Ile


subject: CHEBI:144613


subject: CHEBI:53231

subject_name: poly(ethylene imine)


subject: CHEBI:53231


subject: CHEMBL.COMPOUND:CHEMBL2108905

subject_name: BCG VACCINE


subject: CHEMBL.COMPOUND:CHEMBL2108905


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: CHEBI:27470

subject_name: Folic acid

object_name: essential hypertension


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: Severe Sepsis


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:59527

object_name: Post-Operative Pain


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: UMLS:C4549117

subject_name: novafen


subject: CHEBI:41423

subject_name: Celecoxib

object_name: metastatic colorectal cancer


subject: UMLS:C5782768

subject_name: BUPivacaine 0.25% injectable solution

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: UNII:3HP012Q0FH

object_name: proliferative diabetic retinopathy


subject: UNII:2H1PA8H1EN

subject_name: Pegaptanib


subject: CHEBI:70839

object_name: Chronic lymphocytic leukaemia stage 0


subject: CHEBI:70839

object_name: skin squamous cell carcinoma


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: UMLS:C3640984

subject_name: PepCan

object_name: Neck Carcinoma


subject: UMLS:C3640984

object_name: head and neck neoplasm


subject: UMLS:C3640984

object_name: head and neck cancer


subject: CHEBI:8884

subject_name: Rocuronium

object_name: liver failure


subject: CHEMBL.COMPOUND:CHEMBL5315020

subject_name: VAMIKIBART

object_name: diabetic macular edema


subject: UMLS:C5855389

subject_name: Vamikibart


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Renal Failure, CTCAE


subject: CHEBI:44915

subject_name: Propofol

object_name: kidney failure


subject: CHEBI:44915


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:4026

object_name: Refractory Cutaneous Melanoma


subject: CHEBI:4026

object_name: Refractory Malignant Oral Neoplasm


subject: CHEBI:4026

object_name: Refractory Malignant Mesothelioma


subject: CHEBI:4026

object_name: Refractory Malignant Urinary System Neoplasm


subject: CHEBI:4026

object_name: Refractory Malignant Bone Neoplasm


subject: CHEBI:4026

object_name: Refractory Malignant Skin Neoplasm


subject: CHEBI:4026

object_name: Refractory Malignant Male Reproductive System Neoplasm


subject: CHEBI:4026

object_name: Refractory Malignant Pharyngeal Neoplasm


subject: CHEBI:4026

object_name: Refractory Malignant Endocrine Neoplasm


subject: CHEBI:4026

object_name: Refractory Malignant Female Reproductive System Neoplasm


subject: CHEBI:4026

object_name: Refractory Malignant Thyroid Gland Neoplasm


subject: CHEBI:4026

object_name: Refractory Malignant Soft Tissue Neoplasm


subject: CHEBI:4026

object_name: Refractory Malignant Neoplasm of Multiple Primary Sites


subject: CHEBI:4026

object_name: Recurrent Malignant Male Reproductive System Neoplasm


subject: CHEBI:4026

object_name: Recurrent Malignant Female Reproductive System Neoplasm


subject: CHEBI:4026

object_name: Recurrent Malignant Urinary System Neoplasm


subject: CHEBI:4026

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:4026

object_name: Recurrent Malignant Neoplasm of Multiple Primary Sites


subject: CHEBI:4026

object_name: Recurrent Lip and Oral Cavity Carcinoma


subject: CHEBI:4026

object_name: Recurrent Malignant Thyroid Gland Neoplasm


subject: CHEBI:4026

object_name: Oral neoplasm malignant recurrent


subject: CHEBI:4026

object_name: Recurrent Malignant Pharyngeal Neoplasm


subject: CHEBI:4026

object_name: Recurrent Malignant Soft Tissue Neoplasm


subject: CHEBI:4026

object_name: Recurrent Malignant Endocrine Neoplasm


subject: CHEBI:4026

object_name: Mesothelioma malignant recurrent


subject: CHEBI:4026

object_name: Recurrent Malignant Skin Neoplasm


subject: CHEBI:4027

subject_name: Cyclophosphamide

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:4027

object_name: Refractory Cutaneous Melanoma


subject: CHEBI:4027

object_name: Refractory Malignant Oral Neoplasm


subject: CHEBI:4027

object_name: Refractory Malignant Mesothelioma


subject: CHEBI:4027

object_name: Refractory Malignant Urinary System Neoplasm


subject: CHEBI:4027

object_name: Refractory Malignant Bone Neoplasm


subject: CHEBI:4027

object_name: Refractory Malignant Skin Neoplasm


subject: CHEBI:4027

object_name: Refractory Malignant Male Reproductive System Neoplasm


subject: CHEBI:4027

object_name: Refractory Malignant Pharyngeal Neoplasm


subject: CHEBI:4027

object_name: Refractory Malignant Endocrine Neoplasm


subject: CHEBI:4027

object_name: Refractory Malignant Female Reproductive System Neoplasm


subject: CHEBI:4027

object_name: Refractory Malignant Thyroid Gland Neoplasm


subject: CHEBI:4027

object_name: Refractory Malignant Soft Tissue Neoplasm


subject: CHEBI:4027

object_name: Refractory Malignant Neoplasm of Multiple Primary Sites


subject: CHEBI:4027

object_name: Recurrent Malignant Male Reproductive System Neoplasm


subject: CHEBI:4027

object_name: Recurrent Malignant Female Reproductive System Neoplasm


subject: CHEBI:4027

object_name: Recurrent Malignant Urinary System Neoplasm


subject: CHEBI:4027

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:4027

object_name: Recurrent Malignant Neoplasm of Multiple Primary Sites


subject: CHEBI:4027

object_name: Recurrent Lip and Oral Cavity Carcinoma


subject: CHEBI:4027

object_name: Recurrent Malignant Thyroid Gland Neoplasm


subject: CHEBI:4027

object_name: Oral neoplasm malignant recurrent


subject: CHEBI:4027

object_name: Recurrent Malignant Pharyngeal Neoplasm


subject: CHEBI:4027

object_name: Recurrent Malignant Soft Tissue Neoplasm


subject: CHEBI:4027

object_name: Recurrent Malignant Endocrine Neoplasm


subject: CHEBI:4027

object_name: Mesothelioma malignant recurrent


subject: CHEBI:4027

object_name: Recurrent Malignant Skin Neoplasm


subject: CHEBI:4911

subject_name: Etoposide

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:4911

object_name: Refractory Cutaneous Melanoma


subject: CHEBI:4911

object_name: Refractory Malignant Oral Neoplasm


subject: CHEBI:4911

object_name: Refractory Malignant Mesothelioma


subject: CHEBI:4911

object_name: Refractory Malignant Urinary System Neoplasm


subject: CHEBI:4911

object_name: Refractory Malignant Bone Neoplasm


subject: CHEBI:4911

object_name: Refractory Malignant Skin Neoplasm


subject: CHEBI:4911

object_name: Refractory Malignant Male Reproductive System Neoplasm


subject: CHEBI:4911

object_name: Refractory Malignant Pharyngeal Neoplasm


subject: CHEBI:4911

object_name: Refractory Malignant Endocrine Neoplasm


subject: CHEBI:4911

object_name: Refractory Malignant Female Reproductive System Neoplasm


subject: CHEBI:4911

object_name: Refractory Malignant Thyroid Gland Neoplasm


subject: CHEBI:4911

object_name: Refractory Malignant Soft Tissue Neoplasm


subject: CHEBI:4911

object_name: Refractory Malignant Neoplasm of Multiple Primary Sites


subject: CHEBI:4911

object_name: Recurrent Malignant Male Reproductive System Neoplasm


subject: CHEBI:4911

object_name: Recurrent Malignant Female Reproductive System Neoplasm


subject: CHEBI:4911

object_name: Recurrent Malignant Urinary System Neoplasm


subject: CHEBI:4911

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:4911

object_name: Recurrent Malignant Neoplasm of Multiple Primary Sites


subject: CHEBI:4911

object_name: Recurrent Lip and Oral Cavity Carcinoma


subject: CHEBI:4911

object_name: Recurrent Malignant Thyroid Gland Neoplasm


subject: CHEBI:4911

object_name: Oral neoplasm malignant recurrent


subject: CHEBI:4911

object_name: Recurrent Malignant Pharyngeal Neoplasm


subject: CHEBI:4911

object_name: Recurrent Malignant Soft Tissue Neoplasm


subject: CHEBI:4911

object_name: Recurrent Malignant Endocrine Neoplasm


subject: CHEBI:4911

object_name: Mesothelioma malignant recurrent


subject: CHEBI:4911

object_name: Recurrent Malignant Skin Neoplasm


subject: CHEBI:4911

object_name: Melanoma recurrent


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Ovarian Cancer by FIGO Stage


subject: CHEBI:31355

subject_name: Carboplatin


subject: UNII:HX101E7L6S

subject_name: oregovomab

object_name: Ovarian cancer stage III


subject: UNII:HX101E7L6S

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UNII:HX101E7L6S

object_name: Ovarian cancer stage IV


subject: UNII:HX101E7L6S

object_name: malignant neoplasm of ovary stage IV


subject: UNII:HX101E7L6S


subject: UMLS:C0664206

subject_name: Ovarex


subject: UMLS:C0664206


subject: UMLS:C0664206


subject: UMLS:C0664206


subject: UMLS:C0664206


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: cleft palate


subject: CHEBI:46195

object_name: isolated cleft palate


subject: CHEBI:46195

object_name: cleft palate on exam


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: graft versus host disease


subject: UMLS:C3819106

subject_name: Pedia-Lax Probiotic

object_name: cystic fibrosis


subject: UNII:T6GUK68SDC

object_name: Fabry disease


subject: CHEMBL.COMPOUND:CHEMBL4650410

subject_name: NOVAFERON


subject: UMLS:C3273450

subject_name: Novaferon


subject: CHEBI:132922

object_name: Sprain


subject: CHEBI:132922

object_name: tendinitis


subject: CHEBI:132922

object_name: Muscle Atrophy


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: UMLS:C0700738

subject_name: Profenid


subject: UMLS:C0700738


subject: UMLS:C0700738


subject: CHEBI:6128

subject_name: Ketoprofen


subject: CHEBI:6128


subject: CHEBI:6128


subject: CHEBI:23359

subject_name: colchicine

object_name: hypertriglyceridemia


subject: CHEBI:23359

object_name: Hypertriglyceridemia, CTCAE


subject: UniProtKB:P47802

subject_name: MTX1_MOUSE Metaxin-1 (sprot)

object_name: juvenile idiopathic arthritis


subject: PR:000010755


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C0358845

subject_name: Analgesics and non-steroidal anti-inflammatory drugs


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Infection


subject: UNII:1C6V77QF41

object_name: infectious disease


subject: UNII:1C6V77QF41

object_name: Adverse Event Associated with Infection


subject: CHEBI:29007

subject_name: Ceftriaxone

object_name: abdominal abscess


subject: CHEBI:29007

object_name: peritonitis


subject: CHEBI:29007

object_name: diverticulitis


subject: CHEBI:29007

object_name: cholecystitis


subject: CHEBI:29007

object_name: Cholecystitis, CTCAE 3.0


subject: CHEBI:29007

object_name: Cholecystitis, CTCAE 5.0


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: UNII:L500PR95QA


subject: UNII:L500PR95QA


subject: UNII:L500PR95QA


subject: UNII:L500PR95QA


subject: UNII:L500PR95QA


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:142708


subject: CHEBI:142708


subject: CHEBI:142708


subject: CHEBI:142708


subject: CHEBI:142708


subject: PUBCHEM.COMPOUND:54686904

subject_name: tigecycline


subject: PUBCHEM.COMPOUND:54686904


subject: PUBCHEM.COMPOUND:54686904


subject: PUBCHEM.COMPOUND:54686904


subject: PUBCHEM.COMPOUND:54686904


subject: CHEBI:149836

subject_name: Tigecycline


subject: CHEBI:149836


subject: CHEBI:149836


subject: CHEBI:149836


subject: PR:000005442

subject_name: N-chimaerin

object_name: Inflammation


subject: PR:000005442

object_name: Hypercholesterolemia


subject: PR:000005442

object_name: arteriosclerosis disorder


subject: PR:000005442

object_name: atherosclerosis


subject: CHEBI:232799

subject_name: insulin lispro

object_name: gestational diabetes


subject: CHEBI:232799

object_name: History of gestational diabetes mellitus


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Left ventricular hypertrophy


subject: CHEBI:85078

object_name: Left Ventricular Hypertrophy by ECG Finding


subject: CHEBI:85993

subject_name: Palbociclib

object_name: esophageal cancer


subject: UMLS:C5882632

subject_name: AC220 compound

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5882632

object_name: acute myeloid leukemia


subject: CHEBI:64312

subject_name: Memantine

object_name: mild neurocognitive disorder


subject: CHEBI:64312

object_name: mild cognitive impairment


subject: CHEBI:64312

object_name: endogenous depression


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: Physical function


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: Parkinson disease


subject: GTOPDB:8926

subject_name: glembatumumab vedotin

object_name: Osteosarcoma recurrent


subject: UNII:1568H6A58U


subject: UMLS:C2698156


subject: PUBCHEM.COMPOUND:70105374

subject_name: Pitavastatin Lactone

object_name: type 2 diabetes mellitus


subject: CHEBI:32020

subject_name: Pitavastatin


subject: UMLS:C4309517

object_name: High grade glioma


subject: UMLS:C4309517

object_name: malignant glioma


subject: UMLS:C4309517

object_name: Adult Rhabdomyosarcoma


subject: UMLS:C4309517

object_name: rhabdomyosarcoma


subject: UMLS:C4309517

object_name: Childhood Rhabdomyosarcoma


subject: UMLS:C4309517

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UMLS:C4309517

object_name: medulloblastoma


subject: UMLS:C4309517

object_name: childhood medulloblastoma


subject: UMLS:C4309517

object_name: adult medulloblastoma


subject: UMLS:C4309517

object_name: Childhood Neuroblastoma


subject: UMLS:C4309517

object_name: neuroblastoma


subject: UMLS:C4309517

object_name: Ewing sarcoma


subject: UMLS:C4309517

object_name: glioma susceptibility 1


subject: UMLS:C4309517

object_name: ependymoma


subject: UMLS:C4309517

object_name: childhood ependymoma


subject: UMLS:C4309517

object_name: Newly Diagnosed Childhood Ependymoma


subject: UMLS:C4309517

object_name: Adult Ependymoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEMBL.COMPOUND:CHEMBL2109608

object_name: skin melanoma


subject: UMLS:C2983744

subject_name: Darleukin


subject: CHEBI:45716

subject_name: Vorinostat

object_name: primitive neuroectodermal tumor


subject: CHEBI:45716

object_name: peripheral primitive neuroectodermal tumor


subject: CHEBI:92769

subject_name: Iobenguane


subject: CHEBI:92769


subject: CHEBI:92769

object_name: neoplasm


subject: CHEBI:31554

subject_name: ergometrine maleate

object_name: postpartum hemorrhage


subject: CHEBI:31554

object_name: Post-partum hemorrhage


subject: CHEBI:76018

subject_name: Riociguat

object_name: chronic thromboembolic pulmonary hypertension


subject: PUBCHEM.COMPOUND:24743936

object_name: Bilateral tonic-clonic seizure


subject: PUBCHEM.COMPOUND:24743936

object_name: focal epilepsy


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: adult lymphoma


subject: CHEBI:51254

object_name: lymphoma


subject: CHEBI:51254

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:261649

subject_name: Bismuth subsalicylate


subject: CHEBI:261649


subject: CHEBI:261649


subject: CHEBI:3732

subject_name: Clarithromycin


subject: CHEBI:3732


subject: CHEBI:3732


subject: CHEBI:50687

subject_name: metronidazole hydrochloride


subject: CHEBI:50687


subject: CHEBI:50687


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: UNII:L500PR95QA


subject: UNII:L500PR95QA


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:7772


subject: CHEBI:7772


subject: UNII:P6R62377KV

subject_name: TETRACYCLINE HYDROCHLORIDE


subject: UNII:P6R62377KV


subject: UNII:P6R62377KV


subject: PUBCHEM.COMPOUND:54685734

subject_name: Epitetracycline


subject: PUBCHEM.COMPOUND:54685734


subject: PUBCHEM.COMPOUND:54685734


subject: CHEBI:35006

subject_name: Tetracycline hydrochloride


subject: CHEBI:35006


subject: CHEBI:35006


subject: PUBCHEM.COMPOUND:54675776

subject_name: tetracycline


subject: PUBCHEM.COMPOUND:54675776


subject: PUBCHEM.COMPOUND:54675776


subject: UNII:0P49L952WZ

subject_name: Andrographis paniculata extract

object_name: esophageal squamous cell carcinoma


subject: UMLS:C4745170

subject_name: Adenoviral Tumor-specific Neoantigen Priming Vaccine GRT-C901

object_name: gastroesophageal adenocarcinoma


subject: UMLS:C4745170

object_name: colorectal cancer


subject: UMLS:C4745170

object_name: colorectal carcinoma


subject: UMLS:C4745170

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4745170

object_name: urothelial carcinoma


subject: UMLS:C4745170

object_name: transitional cell carcinoma


subject: UMLS:C4745170

object_name: non-small cell lung carcinoma


subject: UMLS:C4745171

subject_name: mRNA-based Tumor-specific Neoantigen Boosting Vaccine GRT-R902


subject: UMLS:C4745171